Targeted versus universal antifungal prophylaxis among liver transplant recipients - Wikidata - wikimedia - TriplyDB

Targeted versus universal antifungal prophylaxis among liver transplant recipients

Targeted versus universal antifungal prophylaxis among liver transplant recipients

http://www.wikidata.org/entity/Q35194743

about

Invasive Candida Infections in Liver Transplant Recipients: Clinical Features and Risk Factors for Mortality.Is universal antifungal prophylaxis mandatory in adults after lung transplantation? A review and meta-analysis of observational studies.Antifungal prophylaxis in liver transplant recipients: one size does not fit all.Caspofungin versus fluconazole as prophylaxis of invasive fungal infection in high-risk liver transplantation recipients: A propensity score analysis.Voriconazole and the liver.Protective effect of ulinastatin on severe pulmonary infection under immunosuppression and its molecular mechanism.Invasive Candidiasis in Various Patient Populations: Incorporating Non-Culture Diagnostic Tests into Rational Management Strategies.Use of echinocandin prophylaxis in solid organ transplantation.Aspergillosis prophylaxis with voriconazole for 90 days in high-risk liver transplant recipients: Right drug and duration?

P2860

Q33719829-F9D82649-A09C-4685-B686-69FB34F18E7F Q38960760-3E2631FD-AF1A-47E5-BA5B-1A4B1F584976 Q39727899-20679D51-8BD9-4EC7-BA9C-AAF07A868B5E Q40855547-BDC124A2-D9F3-48FB-BCFA-4F3952D3C006 Q42027433-8E4C8208-26DF-4D09-B3F8-CCC5B2EE71D4 Q42376415-41B155C2-6DAC-41E2-B28F-FEEA2F5B3B5D Q49613087-3AC4AB1F-B43F-4F3A-8FFC-2311FC36187C Q50169997-F2C29241-EDD6-4C70-9292-21B40ACEC059 Q54728601-678D57FB-E00D-4F48-BA0A-59D72A21DABA

P2860

Targeted versus universal antifungal prophylaxis among liver transplant recipients

http://www.wikidata.org/entity/Q35194743

description

2014 nî lūn-bûn

@nan

2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Targeted versus universal antifungal prophylaxis among liver transplant recipients

@ast

Targeted versus universal antifungal prophylaxis among liver transplant recipients

@en

type

label

Targeted versus universal antifungal prophylaxis among liver transplant recipients

@ast

Targeted versus universal antifungal prophylaxis among liver transplant recipients

@en

prefLabel

Targeted versus universal antifungal prophylaxis among liver transplant recipients

@ast

Targeted versus universal antifungal prophylaxis among liver transplant recipients

@en

P1433

Q35194743-1FBB385C-6639-41C0-AA50-50894287EC8B

P1476

Q35194743-3D4A2471-7FC2-49C3-BE24-1D66E684DCF3

P2093

Q35194743-241493C4-80B7-4029-A0FE-7F02869B05B9

Q35194743-2A9E6968-A34A-467B-8E1B-55162035C363

Q35194743-33B38F1A-F97D-41B1-AB4C-78BB25648C2C

Q35194743-435CC04B-CE5F-4A52-9BE3-A5716E25845E

Q35194743-59549F14-E003-4D1E-8034-22314EFC2375

Q35194743-7482AAA8-11F5-410E-9CFD-1FEF2C6C4B16

Q35194743-873F0299-0463-40DE-BD28-1AF5523A591A

Q35194743-9AF6F3DE-7E74-4790-8D2B-029D86CC3F56

Q35194743-C609D239-2822-4207-BBBC-24983E2E18B4

Q35194743-FC47C6BC-19CF-4DAF-A8DA-659306FD8750

P2860

Q35194743-02AD60AE-0509-4414-AF13-010043F577FE

Q35194743-0D052165-20CA-449D-B7EB-5FEA496B6A66

Q35194743-1080FFAA-E7B2-4853-9D46-33ACE6D75F48

Q35194743-16493D35-52E6-49B0-A758-EE0FFEAC98A3

Q35194743-288000AF-8EEC-419C-9B19-3EC52C44D31A

Q35194743-33806846-2DAA-48D1-BBA7-AE03CDC72651

Q35194743-3AB1E718-19B4-40D9-BCDD-EAAD58B91A81

Q35194743-41D89359-8636-44F6-A54D-F05F94DE7CFF

Q35194743-490CF6B4-E40A-4D1D-83A6-5723DE571044

Q35194743-4F942E4E-1064-4058-86E2-D424CC77D295

P304

Q35194743-5FDE45E2-A0F4-4483-A923-13B4C6467AE7

P31

Q35194743-9451C863-56DC-47AC-BD23-4684797987A1

P356

Q35194743-53DEC9B7-BE76-416A-8628-4757D1213E8D

P407

Q35194743-858339CF-8255-44B7-BF25-C396A773EE1C

P433

Q35194743-7EC6985A-15C9-493D-AD0C-0DBAEAB2940D

P478

Q35194743-19D25282-5936-49B8-8232-E2E66CA44AFD

P50

Q35194743-875B1965-F161-4897-9805-8F2E79E4D391

P577

Q35194743-812B1396-BA3F-4321-B781-E97E13EEE2D3

P698

Q35194743-1F25A5BB-B3EA-456D-920F-014AC99C9696

P932

Q35194743-883CD8ED-F3C0-4138-A02F-D537071427AD

P356

P1433

American Journal of Transplantation

P1476

Targeted versus universal antifungal prophylaxis among liver transplant recipients

@en

P2093

A Humar

http://www.w3.org/2001/XMLSchema#string

B A Potoski

http://www.w3.org/2001/XMLSchema#string

C J Clancy

http://www.w3.org/2001/XMLSchema#string

E J Kwak

http://www.w3.org/2001/XMLSchema#string

F P Silveira

http://www.w3.org/2001/XMLSchema#string

L G Clarke

http://www.w3.org/2001/XMLSchema#string

M H Nguyen

http://www.w3.org/2001/XMLSchema#string

P Vergidis

http://www.w3.org/2001/XMLSchema#string

R Abdel-Massih

http://www.w3.org/2001/XMLSchema#string

R K Shields

http://www.w3.org/2001/XMLSchema#string

P2860

Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality

Recipient morbidity after living and deceased donor liver transplantation: findings from the A2ALL Retrospective Cohort Study.

Serologic evidence for reactivation of cryptococcosis in solid-organ transplant recipients.

Voriconazole pharmacokinetics in liver transplant recipients.

Invasive Saccharomyces infection: a comprehensive review.

Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

Prospective, observational study of voriconazole therapeutic drug monitoring among lung transplant recipients receiving prophylaxis: factors impacting levels of and associations between serum troughs, efficacy, and toxicity

Zygomycosis in solid organ transplant recipients in a tertiary transplant center and review of the literature.

Factors influencing the magnitude and clinical significance of drug interactions between azole antifungals and select immunosuppressants.

Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/

P304

180-189

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/AJT.12993

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-10-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25359455

http://www.w3.org/2001/XMLSchema#string

P932

4365781

http://www.w3.org/2001/XMLSchema#string